Browse > Article

The Effect of Acupotomy in Trapezius Myofascial Pain Syndrome  

Shin, Hyun-Dong (Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine)
Yoon, Kyung-Bong (Department of Anesthesiology and Pain Medicine, and Anesthesia and Pain Research Institute, Yonsei University College of Medicine)
Yoon, Duck-Mi (Department of Anesthesiology and Pain Medicine, and Anesthesia and Pain Research Institute, Yonsei University College of Medicine)
Kim, Won-Oak (Department of Anesthesiology and Pain Medicine, and Anesthesia and Pain Research Institute, Yonsei University College of Medicine)
Lee, Yong-Kyung (Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine)
Kim, Won-Ju (Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine)
Kim, Shin-Hyung (Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine)
Publication Information
The Korean Journal of Pain / v.17, no.2, 2004 , pp. 198-201 More about this Journal
Abstract
Background: Myofascial pain syndrome is characterized by the presence of hypersensitive points, called 'trigger points'. Trigger points are discrete, focal, hyperirritable spots located in a taut band of skeletal muscle. Numerous therapeutic approaches have been used to treat myofascial pain syndrome. An acupotomy has been applied for various pain conditions in China since the 1980's. This investigation evaluated the efficacy of an acupotomy in myofascial pain syndrome. Methods: Twenty females, with myofascial pain syndrome on trapezius muscle, were treated with an acupotomy. The pretreatment resting and pressing on pain site visual analog scores (VAS) were compared with those 7 days post-treatment. At the same time, the effects of the acupotomy were graded as almost complete pain relief, good relief, slight relief, no change or aggravation at 7 and 14 days post-treatment. Results: The pre-treatment resting and pressing on the pain site mean VAS were 7.2 and 9.2, respectively. The post-treatment resting and pressing on pain site mean VAS decreased significantly to 1.0 and 2.8, respectively (P < 0.05). The effects 7 days post-treatment were complete pain relief = 3 (15%), good relief = 8 (40%) and slight relief = 9 (45%). The effects of 14 days post-treatment were complete pain relief = 4 (20%), good relief = 11 (55%) and slight relief = 5 (25%). Conclusions: An acupotomy is an alternative effective treatment modality for myofascial pain syndrome.
Keywords
acupotomy; myofascial pain syndrome; taut band; trigger point;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 대한통증학회: 통증의학. 2nd ed. 서울, 군자출판사. 2000, pp 144-54
2 Krishnan SK, Benzon HT, Siddiqui T, Canlas B: Pain on intramuscular injection of bupivacaine, ropivacaine, with and without dexamethasone. Reg Anesth Pain Med 2000; 25: 615-9.   PUBMED
3 남상구, 전인숙, 허후만, 황경호, 박욱: 근근막통증증후군 환자에서 체열상을 이용한 근육내자극법의 평가. 대한통증학회지 2003; 16: 54-9.
4 Collins SL, Moore RA, McQuay HJ: The visual analogue pain intensity scale: what is moderate pain in millimeter? Pain 1997; 72: 95-7.
5 宋文閣, 麊維富: 疼痛診療手冊. 濟南, 山東科學技術出版社. 1992, pp 167-75.
6 Lewit K: The needle effect in the relief of myofascial pain. Pain 1979; 6: 83-90.   DOI   PUBMED   ScienceOn
7 Kim PS: Role of injection therapy: review of indications for trigger point injections, regional blocks, facet joint injections, and intra- articular injections. Curr Opin Rheumatol 2002; 14: 52-7.   DOI   PUBMED   ScienceOn
8 Borg-Stein J, Stein J: Trigger points and tender points: one and the same? Does injection treatment help? Rheum Dis Clin North Am 1996; 22: 305-22.
9 Iwama H, Akama Y: The superiority of water-diluted 0.25 % to neat 1 % lidocaine for trigger-point injections in myofascial pain syndrome: a prospective, randomized, double-blinded trial. Anesth Analg 2000; 91: 408-9.   DOI   ScienceOn
10 김혜경, 김성협, 김민정, 임정애, 강포순, 우남식 등: 만성 통증 환자에서의 근육내자극요법. 대한통증학회지 2002; 15: 139-45.
11 Chu J: Dry needling (intramuscular stimulation) in myofascial pain related to lumbosacral radiculopathy. Eur J Phys Med Rehab 1995; 5: 106-21.   DOI
12 Cummings TM, White AR: Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil 2001; 82: 986-92.   DOI   ScienceOn
13 Porta M: A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000; 85: 101-5.   DOI   ScienceOn
14 Chapman CR, Syrjala KL: Measurement of pain, In: Bonica's management of pain. 3rd ed. Edited by Loeser JD, Buttler SH, Chapman CR, Turk DC: Philadelphia, Lippincott Williams & Wilkins. 2001, pp 311-28.
15 Revill SI, Robinson JO, Rosen M, Hogg MI: The reliability of a linear analogue for evaluating pain. Anaesthesia 1976; 31: 1191-8.   DOI   ScienceOn
16 Sola AE, Bonica JJ: Myofascial pain syndrome. In: Bonica's management of pain. 3rd ed. Edited by Loeser JD, Buttler SH, Chapman CR, Turk DC: Philadelphia, Lippincott Williams & Wilkins. 2001, pp 530-56.
17 Alvarez DJ, Rockwell PG: Trigger points: diagnosis and management. Am Fam Physician 2002; 65: 653-60.   PUBMED